Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Xylem Analyst Ratings and Price Targets | NYSE:XYL | Benzinga
Xylem Inc has a consensus price target of $133.56 based on the ratings of 21 analysts. The high is $165 issued by UBS on August 13, 2024. The low is $95 issued by Goldman Sachs on November 3, 2022. The 3 most-recent analyst ratings were released by RBC Capital, Stifel, and Baird on April 30, 2025, respectively. With an average price target of $144.67 between RBC Capital, Stifel, and Baird, there's an implied 15.30% upside for Xylem Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Stifel
Baird
Citigroup
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Xylem
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | Buy Now | 17.16% | RBC Capital | Deane Dray70% | $143 → $147 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | 12.38% | Stifel | Nathan Jones77% | $140 → $141 | Maintains | Buy | Get Alert |
| 04/30/2025 | Buy Now | 16.36% | Baird | Michael Halloran67% | $149 → $146 | Maintains | Outperform | Get Alert |
| 04/16/2025 | Buy Now | 11.58% | Stifel | Nathan Jones77% | $150 → $140 | Maintains | Buy | Get Alert |
| 04/14/2025 | Buy Now | 6.8% | Citigroup | Andrew Kaplowitz83% | $152 → $134 | Maintains | Buy | Get Alert |
| 02/05/2025 | Buy Now | 17.96% | Baird | Michael Halloran67% | $139 → $148 | Maintains | Outperform | Get Alert |
| 01/24/2025 | Buy Now | 19.55% | Stifel | Nathan Jones77% | $166 → $150 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 17.16% | Citigroup | Andrew Kaplowitz83% | $148 → $147 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | — | Wolfe Research | Brad Hewitt48% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 12/11/2024 | Buy Now | 32.3% | Stifel | Nathan Jones77% | $172 → $166 | Maintains | Buy | Get Alert |
| 12/09/2024 | Buy Now | 17.96% | Citigroup | Andrew Kaplowitz83% | $135 → $148 | Upgrade | Neutral → Buy | Get Alert |
| 11/06/2024 | Buy Now | -0.37% | TD Cowen | Joseph Giordano59% | $138 → $125 | Maintains | Hold | Get Alert |
| 11/01/2024 | Buy Now | 29.11% | RBC Capital | Deane Dray70% | $163 → $162 | Maintains | Outperform | Get Alert |
| 11/01/2024 | Buy Now | 22.74% | Baird | Michael Halloran67% | $175 → $154 | Maintains | Outperform | Get Alert |
| 09/03/2024 | Buy Now | 9.99% | TD Cowen | Joseph Giordano59% | → $138 | Downgrade | Buy → Hold | Get Alert |
| 08/13/2024 | Buy Now | 31.51% | UBS | Damian Karas60% | → $165 | Initiates | → Buy | Get Alert |
| 07/31/2024 | Buy Now | 35.49% | Baird | Michael Halloran67% | $155 → $170 | Maintains | Outperform | Get Alert |
| 07/31/2024 | Buy Now | 37.08% | Stifel | Nathan Jones77% | $170 → $172 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 29.91% | RBC Capital | Deane Dray70% | $160 → $163 | Maintains | Outperform | Get Alert |
| 07/18/2024 | Buy Now | 35.49% | Stifel | Nathan Jones77% | $157 → $170 | Maintains | Buy | Get Alert |
| 06/06/2024 | Buy Now | 9.99% | TD Cowen | Joseph Giordano59% | $135 → $138 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | 21.14% | Oppenheimer | Bryan Blair68% | $147 → $152 | Maintains | Outperform | Get Alert |
| 05/29/2024 | Buy Now | 31.51% | Argus Research | John Eade75% | $146 → $165 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 29.11% | RBC Capital | Deane Dray70% | $157 → $162 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 17.16% | Oppenheimer | Bryan Blair68% | $142 → $147 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 7.6% | Mizuho | Brett Linzey67% | $110 → $135 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 23.54% | Baird | Michael Halloran67% | $151 → $155 | Maintains | Outperform | Get Alert |
| 04/18/2024 | Buy Now | 13.17% | Oppenheimer | Bryan Blair68% | $133 → $142 | Maintains | Outperform | Get Alert |
| 04/08/2024 | Buy Now | 10.78% | Citigroup | Andrew Kaplowitz83% | $126 → $139 | Maintains | Neutral | Get Alert |
| 03/21/2024 | Buy Now | 17.96% | Baird | Michael Halloran67% | $141 → $148 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | 19.55% | Exane BNP Paribas | Andrew Buscaglia52% | → $150 | Initiates | → Outperform | Get Alert |
| 02/07/2024 | Buy Now | 19.55% | Stifel | Nathan Jones77% | $136 → $150 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | 0.42% | Citigroup | Andrew Kaplowitz83% | $122 → $126 | Maintains | Neutral | Get Alert |
| 02/07/2024 | Buy Now | 15.57% | RBC Capital | Deane Dray70% | $140 → $145 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | 11.58% | RBC Capital | Deane Dray70% | $120 → $140 | Maintains | Outperform | Get Alert |
| 12/19/2023 | Buy Now | 8.39% | Stifel | Nathan Jones77% | $133 → $136 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | 1.22% | Wolfe Research | Brad Hewitt48% | → $127 | Initiates | → Outperform | Get Alert |
| 12/11/2023 | Buy Now | -13.13% | Citigroup | Andrew Kaplowitz83% | $104 → $109 | Maintains | Neutral | Get Alert |
| 11/21/2023 | Buy Now | -4.36% | Deutsche Bank | Andy Krill65% | $104 → $120 | Upgrade | Hold → Buy | Get Alert |
| 11/01/2023 | Buy Now | -17.11% | Citigroup | Andrew Kaplowitz83% | $101 → $104 | Maintains | Neutral | Get Alert |
| 11/01/2023 | Buy Now | -4.36% | RBC Capital | Deane Dray70% | $123 → $120 | Maintains | Outperform | Get Alert |
| 10/19/2023 | Buy Now | -5.95% | Oppenheimer | Bryan Blair68% | → $118 | Upgrade | Perform → Outperform | Get Alert |
| 10/09/2023 | Buy Now | -19.5% | Citigroup | Andrew Kaplowitz83% | $125 → $101 | Maintains | Neutral | Get Alert |
| 10/02/2023 | Buy Now | -2.77% | Melius Research | Scott Davis67% | → $122 | Upgrade | Hold → Buy | Get Alert |
| 08/29/2023 | Buy Now | — | Seaport Global | Scott Graham74% | — | Initiates | → Neutral | Get Alert |
| 08/03/2023 | Buy Now | 2.81% | RBC Capital | Deane Dray70% | $133 → $129 | Maintains | Outperform | Get Alert |
| 06/29/2023 | Buy Now | -3.56% | Deutsche Bank | Andy Krill65% | → $121 | Initiates | → Hold | Get Alert |
| 06/08/2023 | Buy Now | 6% | Goldman Sachs | Brian Lee53% | → $133 | Reinstates | → Buy | Get Alert |
| 05/31/2023 | Buy Now | 7.6% | Baird | Michael Halloran67% | $122 → $135 | Upgrade | Neutral → Outperform | Get Alert |
| 05/05/2023 | Buy Now | -4.36% | Citigroup | Andrew Kaplowitz83% | $121 → $120 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | 0.42% | RBC Capital | Deane Dray70% | $124 → $126 | Maintains | Outperform | Get Alert |
| 02/14/2023 | Buy Now | -4.36% | Cowen & Co. | Joseph Giordano59% | $115 → $120 | Maintains | Outperform | Get Alert |
| 02/08/2023 | Buy Now | -3.56% | Citigroup | Andrew Kaplowitz83% | $123 → $121 | Maintains | Neutral | Get Alert |
| 02/08/2023 | Buy Now | -16.31% | Mizuho | Brett Linzey67% | → $105 | Maintains | Neutral | Get Alert |
| 01/24/2023 | Buy Now | -1.17% | Stifel | Nathan Jones77% | $115 → $124 | Upgrade | Hold → Buy | Get Alert |
| 01/18/2023 | Buy Now | -8.34% | Morgan Stanley | Connor Lynagh57% | $105 → $115 | Maintains | Overweight | Get Alert |
| 01/13/2023 | Buy Now | -16.31% | Mizuho | Brett Linzey67% | $88 → $105 | Maintains | Neutral | Get Alert |
| 01/04/2023 | Buy Now | — | Raymond James | Pavel Molchanov52% | — | Downgrade | Market Perform → Underperform | Get Alert |
| 12/19/2022 | Buy Now | -8.34% | Stifel | Nathan Jones77% | $113 → $115 | Downgrade | Buy → Hold | Get Alert |
| 12/09/2022 | Buy Now | -1.97% | Citigroup | Andrew Kaplowitz83% | $109 → $123 | Maintains | Neutral | Get Alert |
| 11/16/2022 | Buy Now | 2.81% | Atlantic Equities | Richard Radbourne55% | → $129 | Upgrade | Neutral → Overweight | Get Alert |
| 11/03/2022 | Buy Now | -24.28% | Goldman Sachs | Connor Lynagh57% | $85 → $95 | Maintains | Neutral | Get Alert |
| 11/03/2022 | Buy Now | -16.31% | Morgan Stanley | Connor Lynagh57% | $100 → $105 | Maintains | Overweight | Get Alert |
| 11/02/2022 | Buy Now | -8.34% | TD Cowen | Joseph Giordano59% | $105 → $115 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | -9.14% | RBC Capital | Deane Dray70% | $105 → $114 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | -13.13% | Citigroup | Andrew Kaplowitz83% | $92 → $109 | Maintains | Neutral | Get Alert |
| 11/02/2022 | Buy Now | -12.33% | Credit Suisse | John Walsh77% | $93 → $110 | Maintains | Neutral | Get Alert |
| 10/18/2022 | Buy Now | -16.31% | Cowen & Co. | Joseph Giordano59% | $85 → $105 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/11/2022 | Buy Now | -17.91% | Stifel | Nathan Jones77% | $105 → $103 | Maintains | Buy | Get Alert |
| 10/10/2022 | Buy Now | -26.68% | Citigroup | Andrew Kaplowitz83% | $95 → $92 | Maintains | Neutral | Get Alert |
| 08/29/2022 | Buy Now | -32.25% | Cowen & Co. | Joseph Giordano59% | $75 → $85 | Maintains | Market Perform | Get Alert |
| 08/03/2022 | Buy Now | -16.31% | RBC Capital | Deane Dray70% | $91 → $105 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | -29.86% | Mizuho | Brett Linzey67% | $80 → $88 | Maintains | Neutral | Get Alert |
| 08/03/2022 | Buy Now | -21.1% | Goldman Sachs | Connor Lynagh57% | $87 → $99 | Maintains | Neutral | Get Alert |
| 08/03/2022 | Buy Now | -24.28% | Citigroup | Andrew Kaplowitz83% | $84 → $95 | Maintains | Neutral | Get Alert |
| 08/03/2022 | Buy Now | -23.49% | Credit Suisse | John Walsh77% | $77 → $96 | Upgrade | Underperform → Neutral | Get Alert |
| 07/20/2022 | Buy Now | -25.08% | Stifel | Nathan Jones77% | $90 → $94 | Upgrade | Hold → Buy | Get Alert |
| 07/18/2022 | Buy Now | -36.24% | Mizuho | Brett Linzey67% | $85 → $80 | Maintains | Neutral | Get Alert |
| 06/09/2022 | Buy Now | -20.3% | Morgan Stanley | Connor Lynagh57% | $110 → $100 | Maintains | Overweight | Get Alert |
| 06/01/2022 | Buy Now | -40.22% | Cowen & Co. | Joseph Giordano59% | → $75 | Upgrade | Underperform → Market Perform | Get Alert |
FAQ
What is the target price for Xylem (XYL) stock?
The latest price target for Xylem (NYSE:XYL) was reported by RBC Capital on April 30, 2025. The analyst firm set a price target for $147.00 expecting XYL to rise to within 12 months (a possible 17.16% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xylem (XYL)?
The latest analyst rating for Xylem (NYSE:XYL) was provided by RBC Capital, and Xylem maintained their outperform rating.
When was the last upgrade for Xylem (XYL)?
The last upgrade for Xylem Inc happened on December 9, 2024 when Citigroup raised their price target to $148. Citigroup previously had a neutral for Xylem Inc.
When was the last downgrade for Xylem (XYL)?
The last downgrade for Xylem Inc happened on December 12, 2024 when Wolfe Research changed their price target from N/A to N/A for Xylem Inc.
When is the next analyst rating going to be posted or updated for Xylem (XYL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xylem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xylem was filed on April 30, 2025 so you should expect the next rating to be made available sometime around April 30, 2026.
Is the Analyst Rating Xylem (XYL) correct?
While ratings are subjective and will change, the latest Xylem (XYL) rating was a maintained with a price target of $143.00 to $147.00. The current price Xylem (XYL) is trading at is $125.47, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
